等待开盘 11-05 09:30:00 美东时间
-2.070
-1.31%
Craig-Hallum analyst Jeremy Hamblin reiterated a Buy rating on Five Below today...
10-30 22:16
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总如下。以下是由 The Fly 整理的今日投资者需重点关注的分析师评级动态。 五家获上调评级的公司 ...
10-27 22:25
JP Morgan analyst Matthew Boss upgrades Five Below (NASDAQ:FIVE) from Neutral to Overweight and announces $186 price target.
10-27 19:06
Alpha Modus filed a patent infringement lawsuit against 7-Eleven in the U.S. District Court for the Eastern District of Texas, alleging that 7-Eleven's AI-powered checkout, camera analytics, digital signage, and mobile systems infringe eight of its patents. The patents cover technologies like sensor-driven audience measurement, behavioral analytics, dynamic pricing, and closed-loop measurement. Alpha Modus seeks monetary damages, enhanced relief ...
10-24 11:25
今日重点评级关注:摩根大通:维持Cogent Biosciences"超配"评级,目标价从30美元升至44美元;Piper Sandler:维持Vital Energy"中性"评级,目标价从16美元升至30美元
10-22 10:10
Five Below, a popular retailer for kids, is expanding to the Pacific Northwest with eight new stores opening in Washington and Oregon by November 2025. The stores will offer a wide range of affordable products, from toys and snacks to holiday gifts and decorations. Customers can expect unbeatable deals, with most items priced between $1 and $5, and some beyond that. To celebrate the grand opening, each store will host special events with giveaway...
10-17 12:30
Shares of companies in the broader retail sector are trading higher amid overal...
10-13 23:57
今日重点评级关注:Maxim Group:维持Gain Therapeutics"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Icecure Medical"买入"评级,目标价从2美元升至2.5美元
10-08 09:14
今日重点评级关注:Maxim Group:维持Kazia Therapeutics"买入"评级,目标价从15美元升至20美元;Baird:维持Taysha Gene Therapies"跑赢大市"评级,目标价从7美元升至12美元
10-03 14:32